A carregar...

Potassium-Binding Agents for the Clinical Management of Hyperkalemia

Use of sodium polystyrene sulfonate (SPS) dominates the long-term treatment of hyperkalemia, but two new agents, sodium zirconium cyclosilicate and the recently FDA-approved patiromer, may offer potential advantages compared with SPS.

Na minha lista:
Detalhes bibliográficos
Publicado no:P T
Main Authors: Chaitman, Martin, Dixit, Deepali, Bridgeman, Mary Barna
Formato: Artigo
Idioma:Inglês
Publicado em: MediMedia USA, Inc. 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4699486/
https://ncbi.nlm.nih.gov/pubmed/26765867
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!